Richard Newitter
Stock Analyst at Truist Financial
(4.33)
# 1,302
Out of 4,517 analysts
1005
Total ratings
48.5%
Success rate
7.2%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintained: Buy | $54 | $48.30 | +11.80% | 18 | Jul 16, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $64 → $62 | $44.66 | +38.83% | 51 | Jul 16, 2026 | |
| DXCM DexCom | Maintained: Buy | $87 | $77.86 | +11.74% | 10 | Jul 16, 2026 | |
| EW Edwards Lifesciences | Maintained: Hold | $95 | $89.17 | +6.54% | 40 | Jul 16, 2026 | |
| ITGR Integer Holdings | Maintained: Buy | $110 | $98.46 | +11.72% | 18 | Jul 16, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Hold | $12 → $19 | $19.70 | -3.55% | 36 | Jul 16, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $580 → $510 | $400.52 | +27.33% | 73 | Jul 16, 2026 | |
| GMED Globus Medical | Maintained: Buy | $100 | $81.20 | +23.15% | 55 | Jul 16, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $125 | $105.00 | +19.05% | 59 | Jul 16, 2026 | |
| GKOS Glaukos | Maintained: Buy | $180 | $160.77 | +11.96% | 23 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $117.83 | +35.79% | 33 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $54 | $52.57 | +2.72% | 66 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $18.01 | +16.60% | 16 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $4 | $4.64 | -13.79% | 36 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.35 | - | 41 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $219 → $210 | $166.37 | +26.22% | 15 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $17.39 | +26.55% | 13 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $86 | $83.81 | +2.61% | 48 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $16.57 | +87.14% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.86 | +51.77% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 | $330.87 | -0.26% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 | $93.31 | -1.40% | 69 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 | $138.50 | -2.53% | 66 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $20.55 | -2.68% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $318.63 | +17.38% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.72 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $114.35 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.91 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $242.81 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.65 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.79 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $148 | $162.55 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.58 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.27 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 57.22 → CHF 66.09 | CHF 56.64 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $134.67 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $159.33 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $40.17 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.69 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $180.63 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $44.70 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $99.05 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $36.24 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $22.92 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $250.31 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $5.19 | n/a | 1 | Jul 15, 2016 |
Vericel
Jul 16, 2026
Maintained: Buy
Price Target: $54
Current: $48.30
Upside: +11.80%
Boston Scientific
Jul 16, 2026
Maintained: Buy
Price Target: $64 → $62
Current: $44.66
Upside: +38.83%
DexCom
Jul 16, 2026
Maintained: Buy
Price Target: $87
Current: $77.86
Upside: +11.74%
Edwards Lifesciences
Jul 16, 2026
Maintained: Hold
Price Target: $95
Current: $89.17
Upside: +6.54%
Integer Holdings
Jul 16, 2026
Maintained: Buy
Price Target: $110
Current: $98.46
Upside: +11.72%
Integra LifeSciences Holdings
Jul 16, 2026
Maintained: Hold
Price Target: $12 → $19
Current: $19.70
Upside: -3.55%
Intuitive Surgical
Jul 16, 2026
Maintained: Buy
Price Target: $580 → $510
Current: $400.52
Upside: +27.33%
Globus Medical
Jul 16, 2026
Maintained: Buy
Price Target: $100
Current: $81.20
Upside: +23.15%
Lantheus Holdings
Jul 16, 2026
Maintained: Buy
Price Target: $125
Current: $105.00
Upside: +19.05%
Glaukos
Jul 16, 2026
Maintained: Buy
Price Target: $180
Current: $160.77
Upside: +11.96%
Jul 16, 2026
Maintained: Buy
Price Target: $160
Current: $117.83
Upside: +35.79%
Jul 16, 2026
Maintained: Hold
Price Target: $50 → $54
Current: $52.57
Upside: +2.72%
Jul 16, 2026
Maintained: Buy
Price Target: $18 → $21
Current: $18.01
Upside: +16.60%
Jul 16, 2026
Maintained: Hold
Price Target: $2 → $4
Current: $4.64
Upside: -13.79%
Jul 16, 2026
Maintained: Hold
Price Target: n/a
Current: $19.35
Upside: -
Jul 13, 2026
Maintained: Buy
Price Target: $219 → $210
Current: $166.37
Upside: +26.22%
Jul 13, 2026
Maintained: Buy
Price Target: $22
Current: $17.39
Upside: +26.55%
Jun 4, 2026
Rated: Hold
Price Target: $86
Current: $83.81
Upside: +2.61%
May 11, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $16.57
Upside: +87.14%
May 6, 2026
Reiterated: Buy
Price Target: $18
Current: $11.86
Upside: +51.77%
May 4, 2026
Reiterated: Hold
Price Target: $330
Current: $330.87
Upside: -0.26%
Apr 29, 2026
Reiterated: Hold
Price Target: $92
Current: $93.31
Upside: -1.40%
Mar 4, 2026
Reiterated: Hold
Price Target: $135
Current: $138.50
Upside: -2.53%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $20.55
Upside: -2.68%
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $318.63
Upside: +17.38%
Jan 16, 2026
Maintained: Buy
Price Target: n/a
Current: $59.72
Upside: -
Jun 26, 2025
Maintained: Buy
Price Target: n/a
Current: $114.35
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $28.91
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $242.81
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $10.65
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $32.79
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $148
Current: $162.55
Upside: n/a
Oct 7, 2021
Maintained: Buy
Price Target: n/a
Current: $2.58
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $5.27
Upside: n/a
Aug 17, 2021
Maintained: Hold
Price Target: CHF 57.22 → CHF 66.09
Current: CHF 56.64
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $134.67
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $159.33
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $40.17
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $5.69
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $180.63
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $44.70
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $99.05
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $36.24
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $22.92
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $250.31
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $5.19
Upside: n/a